The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis

Allergy and Asthma Proceedings

Volumn 19, Issue 1, 1998, Pages 23-29

  Kaiser, Harold B ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE;

ADOLESCENT; ADULT; AEROSOL; AGED; ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NOSE MUCOSA; PERENNIAL RHINITIS; RANDOMIZED CONTROLLED TRIAL; SECRETION;

ADOLESCENT; ADULT; AEROSOLS; AGED; CHOLINERGIC ANTAGONISTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IPRATROPIUM; MALE; MIDDLE AGED; NASAL MUCOSA; RHINITIS, ALLERGIC, PERENNIAL;

EID: 0031613158     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/108854198778557962     Document Type: Article

References (2)

1. Smith JM. Epidemiology and natural history of asthma, allergic rhinitis and atopic dermatitis (eczema). In Allergy: Principals and Practice, Vol. 2, Middleton E Jr, Reed CD, Ellis E, Adkinson NF Jr, Yunginger JW (Eds) St Louis: Mosby-Year Book 1988, 891-929.
2. Meltzer EO, Orgel HA, Bronsky EA, et al. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis. A study of its effect on their symptoms, quality of life, and nasal cytology. J Allergy Clin Immunol 90:242-249, 1992.